We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Trellus Health Plc | LSE:TRLS | London | Ordinary Share | GB00BNNFM402 | ORD GBP0.0006 |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.625 | 300,000 | 07:49:21 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 0.60 | 0.65 | 0.625 | 0.625 | 0.625 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Offices Of Medical Doctors | USD 19k | USD -6.34M | USD -0.0392 | -0.16 | 1.01M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 15:35:51 | O | 300,000 | 0.60 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 30/9/2024 | 06:00 | UK RNS | Trellus Health PLC Holding(s) in Company |
| 26/9/2024 | 17:12 | ALNC |  EARNINGS: Zephyr Energy interim loss narrows; Eqtec expenses surge |
| 26/9/2024 | 06:00 | UK RNS | Trellus Health PLC Half-year Report |
| 19/9/2024 | 06:00 | UK RNS | Trellus Health PLC Directorate Change |
| 16/9/2024 | 06:00 | UK RNS | Trellus Health PLC Notice of Results |
| 15/7/2024 | 17:07 | UK RNS | Trellus Health PLC Holding(s) in Company |
| 26/6/2024 | 06:00 | UK RNS | Trellus Health PLC Holding(s) in Company |
| 24/6/2024 | 16:15 | UK RNS | Trellus Health PLC Holding(s) in Company |
| 19/6/2024 | 14:53 | UK RNS | Trellus Health PLC Holding(s) in Company |
| 14/6/2024 | 16:19 | UK RNS | Trellus Health PLC Holding(s) in Company |
Trellus Health (TRLS) Share Charts1 Year Trellus Health Chart |
|
1 Month Trellus Health Chart |
Intraday Trellus Health Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 12/12/2024 | 15:55 | Trellus Health - Digital Health Solution for complex chronic conditions | 391 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 2024-12-13 15:35:53 | 0.60 | 300,000 | 1,800.00 | O |
| Top Posts |
|---|
Posted at 14/12/2024 08:20 by Trellus Health Daily Update Trellus Health Plc is listed in the Offices Of Medical Doctors sector of the London Stock Exchange with ticker TRLS. The last closing price for Trellus Health was 0.63p.Trellus Health currently has 161,508,333 shares in issue. The market capitalisation of Trellus Health is £1,001,352. Trellus Health has a price to earnings ratio (PE ratio) of -0.16. This morning TRLS shares opened at 0.63p |
Posted at 12/12/2024 15:55 by tia01 It’s been a horrible week in trls with sells and few if any buys keeping the shares at all time lows.Any news leak could cause a huge positive reaction rally which would be welcome news for current shareholders nursing huge losses |
Posted at 07/12/2024 14:51 by ravenrussia I am also looking into buying this next week as bio technology companies are now being tipped as the best sector to be in.From what i have read today TRLS are waiting on some important deals from America They seem to have enough cash to last well into final quarter of 2025 ( assuming no revenues at all) I will be buying some on Monday |
Posted at 05/12/2024 16:03 by allesandro Guys this just popped up on my radar,any LTH give a quick outline of what is happening at TRLS ? why the big fall in share price ? all i see is positive RNS |
Posted at 05/12/2024 08:34 by tia01 Will selling price move upwards!. |
Posted at 31/10/2024 11:02 by tomboyb Probably the easiest Job in the world -Sit back / relax /spend and when money runs out point out market conditions - Those TRLS videos are there to see - No shame - |
Posted at 17/10/2024 10:53 by wan Trellus Health® is commercializing the provision of digital chronic condition management solutionsTrellus' cash position is currently circa £4-5m, with a market cap currently at £1.2m. Whilst I don't dispute the dire performance in terms of both share price performance and commercial progress, it appears quite clear that Trellus Health's features and capabilities cost a lot more to develop and market compared to the current market cap (shareholders have certainly paid for it!), and even including the possibility of a significant bid premium, not to mention the current cash position, another player could acquire what appears to be a very cheap option. Even a significant premium to the current share price could still be below the cash position, and with some companies in the sector apparently looking for strategic acquisitions that will add new features and capabilities into their products, Trellus could arguably be on certain radars. Particularly as a key benefit of Trellus' methodology is that its condition-agnostic (it can be utilised in management of many more chronic conditions) and Trellus has revealed that they are in discussions with potential partners across all their commercial models, including two later-stage discussions. The following article provides further food for thought - Digital health deal count declines in Q3, but check sizes stabilize: Rock Health Start ups notched just 110 deals in the third quarter, compared with 133 in the second quarter. But average deal size held steady. Published Oct. 14, 2024 Now, digital health companies are looking to build up their offerings, sometimes through strategic acquisitions, to compete with legacy healthcare firms, according to the latest Rock Health report. The sector has seen relatively few cases of companies acquiring their competitors this year, a type of M&A that drove increased consolidation in 2021 and 2022. But the analysis noted some digital health companies are using M&A to add new features and capabilities into their products, rather than just grow the company overall. That could be especially wise after a period of valuation decline among digital health startups, report authors Adriana Krasniansky, Sari Kaganoff and Tiffany Marie Ramos wrote. “Acquiring a startup with a built-out product and sales, potentially at a depressed price, can be more affordable than building a new product and customer base from scratch,” they said. Full story - As I said previously, I am not holding my breath given the absolutely dire performance to date (I have grudgingly accepted and partly mitigated the near total loss). Please conduct your own research when making investment decisions, as the originator, market commentators, or the threads contributors, could be either wrong or inaccurate. |
Posted at 25/6/2024 11:43 by 12smith Think last of harwood sell now getting mopped up as buy price slipping a tad . |
Posted at 23/4/2024 10:55 by idomeneo Total of 180 downloads (all time):More data about Trellus Health Price Free to download Total downloads 180 Recent downloads 16 Rating No ratings Ranking Not ranked Version 1.96.0 APK size 43.8 MB Number of libraries ? Suitable for Everyone Ads NO ads |
Posted at 01/12/2023 12:24 by hatfullofsky TRLS are now trading 40% below their cash level |
Posted at 14/12/2021 10:43 by cambridgedon Thanks Wan.Seems that the RENX and TRls share prices are suffering at the same time! In one sense they both represent a lot lower risk than at the IPO/launch price but the recent falls have also got many to question what they are really worth. Thoughts? CD |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
